Researchers are exploring ways to improve treatment with semaglutide for patients with chronic kidney disease, which may involve overcoming various barriers. The treatment is related to GLP-1 delivery and receptor agonists, which have potential applications in managing multiple diseases. The specifics of these efforts and their potential impact on patient care are being investigated through various studies and technologies, including microneedle technology.